Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

No cure for female pattern hair loss, but various effective treatments exist.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Goat reproductive activity and coat growth are affected by light and temperature, with temperature altering prolactin levels and hair growth, but not melatonin or estrus onset.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Some men with early hair loss may have a condition similar to PCOS in women.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.